Novabay Pharmaceuticals (NBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBY | ORKA | AMLX | ||
| Company | Novabay Pharmaceuticals | Oruka Therapeutics Inc | Amylyx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 7.39 | 27.27 | 11.45 | ||
| High | 11.14 | 28.51 | 12.19 | ||
| Low | 7.19 | 26.78 | 11.42 | ||
| Latest | 10.64 | 27.81 | 11.99 | ||
| Change | +3.25 | +1.19 | +0.61 | ||
| % Change | +43.98% | +4.47% | +5.36% | ||
| Volume | 3,372,000 | 455,500 | 1,457,500 | ||
| 20-Day Average Volume | 2,642,550 | 726,145 | 1,737,490 | ||
| Previous Close | 7.39 | 26.62 | 11.38 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.72 | 29.87 | 12.27 | ||
| 20-Day Raw Stochastic | 94.88% | 34.82% | 37.42% | ||
| 20-Day Relative Strength | 84.76 | 47.19 | 43.51 | ||
| Weighted Alpha | +77.69 | +135.34 | +169.14 | ||
| Today's Opinion | 100% Buy | 56% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 8% Buy | ||
| Last Month's Opinion | 32% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +71.61% since 12/30/25 | -4.50% since 12/30/25 | -0.08% since 12/30/25 | ||
| Low | 5.21 on 12/31/25 | 25.23 on 01/05/26 | 10.83 on 01/05/26 | ||
| High | 11.14 on 01/07/26 | 30.81 on 12/31/25 | 12.19 on 01/07/26 | ||
| 1-Month | |||||
| %Chg | +779.34% since 12/05/25 | -9.82% since 12/05/25 | -15.56% since 12/05/25 | ||
| Low | 1.19 on 12/08/25 | 25.23 on 01/05/26 | 10.83 on 01/05/26 | ||
| High | 11.14 on 01/07/26 | 32.64 on 12/23/25 | 14.76 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +744.44% since 10/07/25 | +35.20% since 10/07/25 | -11.12% since 10/07/25 | ||
| Low | 0.86 on 11/21/25 | 20.25 on 10/08/25 | 10.83 on 01/05/26 | ||
| High | 11.14 on 01/07/26 | 32.64 on 12/23/25 | 16.96 on 10/21/25 | ||
| 6-Month | |||||
| %Chg | +1,505.07% since 07/07/25 | +109.26% since 07/07/25 | +77.37% since 07/07/25 | ||
| Low | 0.54 on 08/15/25 | 12.84 on 08/11/25 | 6.57 on 07/08/25 | ||
| High | 11.14 on 01/07/26 | 32.64 on 12/23/25 | 16.96 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,340,757 | 1,346,254 | 1,316,742 | ||
| Shares Outstanding, K | 126,011 | 48,409 | 109,820 | ||
| Annual Sales | 9,780,000 | 0 | 87,370,000 | ||
| Annual Net Income | -7,220,000 | -83,720,000 | -301,740,000 | ||
| Last Quarter Sales | 520,000 | 0 | 0 | ||
| Last Quarter Net Income | -1,290,000 | -30,280,000 | -34,390,000 | ||
| 60-Month Beta | 0.09 | -0.39 | -0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 11/07/25 | -0.55 on 11/12/25 | -0.37 on 11/06/25 | ||
| Latest Earnings Date | 04/01/26 | 03/05/26 | 03/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 03/28/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||